Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin for Tinnitus
NCT05650645Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Jan 2023
- Primary completion
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in tinnitus, sponsored by University of Minnesota. Started Jan 2023; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT05650645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05650645.